The Cell & Gene Therapy manufacturing Services market is driven by increasing investments in advanced therapies, rising ...

Ocugen ($OCGN) is grabbing investors’ attention with its stock climbing 195% in the past year and its modifier gene therapy ...

Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories (Charles River), a global industry-leading drug discovery, preclinical ...

Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

But all is not well in the world of sickle cell gene therapy. Image Kendric underwent four days of intense chemotherapy to clear his bone marrow, which makes way for his treated cells to ...

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

The technique is called in vivo CAR-M therapy. "The nomination of the two autoimmune targets is a significant milestone in ...

Cryopreservation – freezing CGT biological materials at ultralow temperatures – helps minimize material loss of function during product shipment and storage, which occur before therapies are delivered ...

There's new hope for people with sickle cell disease which affects mainly African Americans. It's gene therapy research at ...

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...